The McEwen Investment Report
David McEwen
Head Researcher
Professional Journalist Turned Investment Analyst
After writing for The Financial Times, Reuters News Service, National Business Review David turned his talents towards investment analysing. Over 30 years of watching the markets David offers timely and easy-to-understand commentary on shares that he classifies through the use of 9 unique key criteria.

The McEwen Investment Report
Decades of success
The McEwen Investment Report was established in New Zealand in 1998, and has since provided readers with accurate, timely and effective guidance to the share market. Growing to become a global title, offering fresh thinking and analysis of shares on the NZ, Australian, UK, and US stock markets. The newsletter offers easy-to-understand commentary on shares to buy, hold and sell. Using David McEwen's unique 9 Key Criteria we find financially sound businesses that are temporarily undervalued by other investors.
This has proven to be a low-risk strategy that to date has delivered returns that are substantially above the overall market.
The report is refreshingly free of jargon and complicated calculations, making it easy to read and understand, while every company profiled comes with a firm trading recommendation.
Information That Pays
Checkout some of Dave's latest updates!
Today US:NAKD was the fastest moving #stock on the entire US #market, rising 123% to 29c after regaining its #trading rights following a period of suspension.
This stock is only for the brave but it is good to see something with a #Kiwi connection taking it to the #Americans.
After #trading sideways along the moving average for nearly two months, Sky Network Television (AU:SKT) has finally broken from the support line! ๐Up 18.5% for the week, #investors may want to keep an eye on this one. https://t.co/hbdP7p005S
This is a graph of how the #NZX50 moved today. Anyone who thinks they can #trade right now based on their expectations of how the #USElection will go are playing with fire ๐ฅ๐ฅ๐ฅ https://t.co/c3t4fHhQZO
Fisher and Paykel Healthcare (NZ: FPH) hit its high point of $37.68 in September and is currently slowly making a recovery. It was, however, unable to break its previous high point before falling. ๐Today it has already dropped 2%, showing that the #shares may have topped out https://t.co/pgCXzEL4dd
Save up to 50% on a subscription to the McEwen Investment Report!
Receive a money back guarantee on any unsent issues.
Join The McEwen Team!
Great Info & Fantastic Insights
5/5
My average buy price for A2 Milk, which you recommended, is 66c compared with the current price of over $12.00. I still have 5715 shares and current gains total $87,500.00. Over 46 yrs of fiddling about on the NZ market this is by far the best return.
- A McCullough, Christchurch
Good Picks
4.5/5
I made 30% in two months from your pick of Evraz. I donโt know how you find such shares that others have never even heard of, but I am very pleased that you do.
- L Jollands, Auckland